BHC vs PATH · rev $9.63B vs P/E 19, rev $1.61B
Bausch Health Companies Inc (BHC) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Bausch Health Companies Inc (BHC) is a drug manufacturers - specialty & generic company listed on NYSE.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported BHC revenue for 2024-12-31 was $9.63B. Net income was -$72.0M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. BHC currently screens at market cap $1.78B.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
BHC currently screens at market cap $1.78B. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the BHC and PATH stock pages for the full models.
Not investment advice.